Pharmacological analysis of the inhibition produced by moxonidine and agmatine on the vasodepressor sensory CGRPergic outflow in pithed rats

Atlas, 1994, Identifying clonidine-displacing substance, Science, 266, 462, 10.1126/science.7939689 Avilés-Rosas, 2017, Olcegepant blocks neurogenic and non-neurogenic CGRPergic vasodepressor responses and facilitates noradrenergic vasopressor responses in pithed rats, Br. J. Pharmacol., 174, 2001, 10.1111/bph.13799 Bayne, 1996, Revised guide for the care and use of laboratory animals available. American physiological society, Physiologist, 39, 208 Chan, 2010, Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model, Br. J. Pharmacol., 160, 1316, 10.1111/j.1476-5381.2010.00733.x Cobos-Puc, 2009, Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats, Eur. J. Pharmacol., 616, 175, 10.1016/j.ejphar.2009.06.003 Cowley, 1992, Long-term control of arterial blood pressure, Physiol. Rev., 72, 231, 10.1152/physrev.1992.72.1.231 Cuesta, 2014, Role of 5-HT7 receptors in the inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats, Vasc. Pharmacol., 63, 4, 10.1016/j.vph.2014.06.009 Doods, 2000, Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist, Br. J. Pharmacol., 129, 420, 10.1038/sj.bjp.0703110 Edvinsson, 2010, Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries, Cephalalgia, 30, 1233, 10.1177/0333102410362122 Ernsberger, 1999, The I1-imidazoline receptor and its cellular signaling pathways, Ann. N. Y Acad. Sci., 881, 35, 10.1111/j.1749-6632.1999.tb09339.x Ernsberger, 1997, The I1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla, Am. J. Physiol., 273, R1572 Flamez, 1997, Pharmacological characterization of I1 and I2 imidazoline receptors in human striatum, Neurochem. Int., 30, 25, 10.1016/S0197-0186(96)00040-X Gentili, 2003, Imidazoline binding sites (IBS) profile modulation: key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analogues, J. Med. Chem., 46, 2169, 10.1021/jm021113r Goadsby, 2002, Migraine — current understanding and treatment, New Engl. J. Med., 346, 257, 10.1056/NEJMra010917 González-Hernández, 2011, The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes, Eur. J. Pharmacol., 659, 233, 10.1016/j.ejphar.2011.03.035 Hieble, 1996, Subclassification and nomenclature of alpha 1- and alpha 2-adrenoceptors, Prog. Drug Res., 47, 81 Legislation for the protection of animals used for scientific purposes Directive 2010/63/EU. 〈http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm〉. Li, 1994, Agmatine: an endogenous clonidine-displacing substance in the brain, Science, 263, 966, 10.1126/science.7906055 Loscalzo, 2015, Basic biology of the cardiovascular system Lozano-Cuenca, 2009, Effect of some acute and prophylactic antimigraine drugs on the vasodepressor sensory CGRPergic outflow in pithed rats, Life Sci., 84, 125, 10.1016/j.lfs.2008.11.008 Lundberg, 1996, Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide, Pharmacol. Rev., 48, 113 MaassenVanDenBrink, 2016, Wiping Out CGRP: Potential cardiovascular risks, Trends Pharmacol. Sci., 37, 779, 10.1016/j.tips.2016.06.002 Manrique-Maldonado, 2015, Pharmacological evidence that histamine H3 receptors inhibit the vasodepressor responses by selective stimulation of the rat perivascular sensory CGRPergic outflow, Eur. J. Pharmacol., 754, 25, 10.1016/j.ejphar.2015.02.017 Manrique-Maldonado, 2014, The role of pre-junctional D2 -like receptors mediating quinpirole-induced inhibition of the vasodepressor sensory CGRPergic out-flow in pithed rats, Basic Clin. Pharmacol. Toxicol., 114, 174, 10.1111/bcpt.12122 McGrath, 2010, Guidelines for reporting experiments involving animals: the ARRIVE guidelines, Br. J. Pharmacol., 160, 1573, 10.1111/j.1476-5381.2010.00873.x Munk, 1996, Synthesis and pharmacologic evaluation of 2-endo-amino-3-exo- isopropylbicyclo[2.2.1]heptane: a potent imidazoline1 receptor specific agent, J. Med. Chem., 39, 1193, 10.1021/jm960012o Rubino, 1996, Capsaicin-sensitive sensory-motor neurotransmission in the peripheral control of cardiovascular function, Cardiovasc. Res., 31, 467, 10.1016/S0008-6363(96)00023-5 Russell, 2014, Calcitonin gene-related peptide: physiology and pathophysiology, Physiol. Rev., 94, 1099, 10.1152/physrev.00034.2013 Taguchi, 1992, Endogenous calcitonin gene-related peptide mediates nonadrenergic noncholinergic depressor response to spinal cord stimulation in the pithed rat, Circ. Res., 71, 357, 10.1161/01.RES.71.2.357 van Zwieten, 1997, Centrally acting antihypertensives: a renaissance of interest. Mechanisms and haemodynamics, J. Hypertens. Suppl., 15, S3, 10.1097/00004872-199715011-00001 Villalón, 2008, Pharmacological profile of the clonidine-induced inhibition of vasodepressor sensory outflow in pithed rats: correlation with alpha(2A/2C)-adrenoceptors, Br. J. Pharmacol., 154, 51, 10.1038/bjp.2008.49 Westfall, 2011, Neurotransmission: the autonomic and somatic motor nervous systems